Biotechnology industry in Italy

Biotechnology industry in Italy is a highly innovative and fast-growing sector dedicated to research.
At the end of 2019, there are 696 biotech companies active in Italy.
Industry.
The turnover exceeds 12 billion euros, the number of employees exceeds 13,000 units. Between 2017 and 2019, over 50 new innovative start-ups active in biotechnology were registered.
Vaccine.
In the laboratories of the IRBM Science Park a team of Italian and American researchers has developed the Chad3Ebola-Zaire anti-ebola vaccine, a monovalent adenovirus capable of neutralizing the «Zaire» strain of the virus, conceived and produced by OKAIROS, a biotech company founded by Prof. Riccardo Cortese, with whom IRBM set up the Advent equal joint venture.
Research.
The research intensity of the biotech sector is significantly higher than that found for the Italian industry as a whole.